白及膠雙層膜 > 無白及膠兒黃散雙層膜;經(jīng)過1、5、10 mg/mL濃度的EHGBF處理后,HeLa細胞凋亡率與對照組比較均顯著升高(P<0.05);EHGBF在大劑量使用下無致死性,對皮膚及陰道幾乎沒有刺激性。結(jié)論 EHGBF可抑制人宮頸癌HeLa細胞增殖并促進其凋亡,無急性毒性,對皮膚無刺激性,對陰道黏膜幾乎沒有刺激性,安全性較好。;Objective To investigate the efficacy and safety of skin medication for human cervical cancer with HeLa cell proliferation inhibition and apoptosis by Erhuangsan gum-bletilla double-film (EHGBF). Methods MTT assay was used to investigate the effects of different concentrations (0.1, 1.0, 5.0, 10.0 mg/mL) of EHGBF, Erhuangsan double-film without gum-bletilla, gum-bletilla double-film and blank matrix film on cell proliferation inhibition. The effects of apoptosis were detected by flow cytometry. The vaginal irritancy of the film was investigated by the vaginal acute toxicity test of the film, the irritating test of the intact skin and the damaged skin of the rabbit, and the visual observation of the vaginal material of the rabbit after the administration and the pathological observation of the paraffin section. Result The blank matrix membrane had no inhibitory effect on HeLa cell proliferation, while EHGBF, gum-bletilla double-film, and erhuangsan double-film without gum-bletilla had significant inhibitory effect on HeLa cell proliferation (P<0.05). The inhibitory effect on the proliferation of HeLa cells was that EHGBF > gum-bletilla double-film > erhuangsan double-film without gum-bletilla. The apoptosis rate of HeLa cells treated with EHGBF was significantly higher than that of the control group (P<0.05). EHGBF was not lethal at high doses, and had little irritation to the skin and vagina. Conclusion EHGBF can inhibit the proliferation and promote apoptosis of human cervical cancer HeLa cells, no acute toxicity and irritation to the skin, almost no irritating to vaginal mucosa, and good safety."/>